Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01301521 · ClinicalTrials.gov registry record · NA
Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics
A NA study, sponsored by Mike O'Callaghan Military Hospital.
- Completed
- Registry status
- NA
- Development phase
- 229
- Enrollment target
NCT01301521 is a NA study that has completed, run by Mike O'Callaghan Military Hospital. The registered enrollment target is 229 participants.
The verdict
NCT01301521, a NA study, has completed, sponsored by Mike O'Callaghan Military Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 229 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether water-soluble cinnamon extract plus aggressive lifestyle intervention is effective in lowering blood glucose in pre-diabetic patients when compared to aggressive lifestyle therapy plus placebo.
Interventions
- DRUG water-soluble cinnamon extract (Cinnulin PF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2013-06-11 |
| Est. Completion | 2019-04-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01301521
The ClinicalTrials.gov registry entry for NCT01301521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mike O'Callaghan Military Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which water-soluble cinnamon extract (Cinnulin PF) is the first listed.
NCT01301521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01301521 about?
NCT01301521 is a clinical study titled "Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics". The purpose of this study is to assess whether water-soluble cinnamon extract plus aggressive lifestyle intervention is effective in lowering blood glucose in pre-diabetic patients when compared to aggressive lifestyle therapy plus placebo.
What is the current status of trial NCT01301521?
This trial is currently completed. It is a NA study. The enrollment target is 229 participants. The study started on 2013-06-11. Estimated completion is 2019-04-26.
What interventions are being tested in trial NCT01301521?
The interventions under investigation include: water-soluble cinnamon extract (Cinnulin PF) (DRUG).
Who is sponsoring clinical trial NCT01301521?
This trial is sponsored by Mike O'Callaghan Military Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.